Invention Grant
- Patent Title: Treatment with factor ix-albumin fusion protein
-
Application No.: US13855434Application Date: 2013-04-02
-
Publication No.: US09775888B2Publication Date: 2017-10-03
- Inventor: David J. Ballance , Darrell Sleep
- Applicant: David J. Ballance , Darrell Sleep
- Applicant Address: DK Lyngby
- Assignee: ALBUMEDIX A/S
- Current Assignee: ALBUMEDIX A/S
- Current Assignee Address: DK Lyngby
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/48 ; A61K9/00 ; A61K38/21 ; A61K38/38 ; C07K14/56 ; C07K14/61 ; C07K14/62 ; C07K14/65 ; C07K14/705 ; C07K14/715 ; C07K14/76 ; C07K14/765 ; C12N15/62 ; C12N9/96 ; A61K47/48 ; A61K47/42 ; A61K48/00 ; A61K39/00
Abstract:
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
Public/Granted literature
- US20140010798A1 ALBUMIN FUSION PROTEINS Public/Granted day:2014-01-09
Information query
IPC分类:
